BIOMAT Database Logo BIOMAT Database Logo

Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats. 2014

Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, PO Box 14115-331, Tehran, Iran.

The aim of this study was to evaluate the effects of orexin type-1 receptor (OX1R) antagonism in locus coeruleus (LC) nucleus on the development of morphine physical dependence in rats. Animals were rendered dependent on morphine by subcutaneous (s.c.) administration of morphine sulfate (6, 16, 26, 36, 46, 56 and 66 mg/kg, 2 ml/kg) at set intervals of 24 h for 7 days. Immediately before each morphine administration, the animals received intra-LC administration of SB-334867 (3 mM, 0.2 μl), a selective orexin type-1 receptor antagonist. On day 8, naloxone (3 mg/kg, i.p.) was injected and physical dependence was evaluated for 30 min. Our results showed that administration of OX1R antagonist before each morphine injection significantly decreased somatic signs of naloxone-induced morphine withdrawal syndrome, including defecation, wet-dog shake, diarrhea, jumping, scratching, and teeth chattering. These results suggest that the activation of OX1R in LC nucleus might be involved in the development of morphine dependency.

UI MeSH Term Description Entries
D008125 Locus Coeruleus Bluish-colored region in the superior angle of the FOURTH VENTRICLE floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the PERIAQUEDUCTAL GRAY. Locus Caeruleus Complex,Locus Caeruleus,Locus Ceruleus,Locus Ceruleus Complex,Locus Coeruleus Complex,Nucleus Pigmentosus Pontis,Caeruleus Complex, Locus,Complex, Locus Caeruleus,Complex, Locus Ceruleus,Complex, Locus Coeruleus,Pontis, Nucleus Pigmentosus
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009021 Morphine Dependence Strong dependence, both physiological and emotional, upon morphine. Morphine Abuse,Morphine Addiction,Abuse, Morphine,Addiction, Morphine,Dependence, Morphine
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D000068796 Orexin Receptor Antagonists Substances that bind to and inhibit the action of OREXIN RECEPTORS. Drugs in this class have been used as SLEEP AIDS, PHARMACEUTICAL. Dual Orexin Receptor Antagonist,Orexin Receptor Antagonist,Dual Orexin Receptor Antagonists,Orexin Receptor Blockers,Antagonist, Orexin Receptor,Receptor Antagonist, Orexin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001583 Benzoxazoles Benzoxazole
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol

Related Publications

Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons.
November 2017, Neuroscience,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
October 2010, Neuroscience letters,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats.
June 2021, Neuroscience letters,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
The role of orexin type-1 receptors in the development of morphine tolerance in locus coeruleus neurons: An electrophysiological perspective.
September 2016, Brain research,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
March 2016, Neuroscience letters,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Blockade of orexin type 1 receptors inhibits the development of morphine tolerance in lateral paragigantocellularis nucleus: an electrophysiological approach.
August 2014, Brain research,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors.
October 2015, Brain research,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Blockade of orexin receptor 1 attenuates the development of morphine tolerance and physical dependence in rats.
December 2012, Pharmacology, biochemistry, and behavior,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
Orexin type-1 receptor inhibition in the rat lateral paragigantocellularis nucleus attenuates development of morphine dependence.
April 2020, Neuroscience letters,
Yousof Mousavi, and Hossein Azizi, and Javad Mirnajafi-Zadeh, and Mohammad Javan, and Saeed Semnanian
The role of locus coeruleus nucleus TRPV1 receptors in the development and expression of morphine dependence.
October 2019, Iranian journal of basic medical sciences,
Copied contents to your clipboard!